Estrogens: Mechanisms of neuroprotective effects

Journal of Physiology and Biochemistry

Volumn 68, Issue 3, 2012, Pages 455-460

  Petrovska, Suncica ^a   Dejanova, Beti ^a   Jurisic, Vladimir ^b  

^a SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

^b UNIVERSITY OF KRAGUJEVAC   (Serbia)

Author keywords

Aging; Estrogens; Neurodegenerative diseases; Neuroprotection

Indexed keywords

ESTRADIOL; ESTROGEN;

ALZHEIMER DISEASE; CEREBROVASCULAR ACCIDENT; HUMAN; NEUROPROTECTION; PARKINSON DISEASE; REVIEW;

AGING; ALZHEIMER DISEASE; ANIMALS; COGNITION; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; MALE; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS;

EID: 84871259242     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-012-0159-x     Document Type: Review

References (31)

1. Aliev G, Smith MA, Seyidov D, Neal ML, Lamb BT, Nunomura A, Gasimov EK, Vinters HV, Perry G, LaManna JC, Friedland RP (2002) The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. Brain Pathol 12:21-35
2. Borras C, Gambini J, Gomez-Cabrera MC, Sastre J, Pallardo FV, Mann GE, Vina J (2005) 17beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2 (MAPK)/NFkappa B cascade. Aging Cell 4:113-118
3. Cardona-Gomez GP, Mendez P, DonCarlos LL, Azcoitia I, Garcia-Segura LM (2001) Interactions of estrogens and insulin-like growth factor-I in the brain: Implications for neuroprotection. Brain Res Rev 37:320-334
4. Dhandapani KM, Brann DW (2002) Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biol Reprod 67(5):1379-1385
5. Diaz-Brinton R, Chen S, Montoya M, Hseih D, Minaya J, Kim J, Chu HP (2000) The Women's Health Initiative estrogen replacement therapy is neurotrophic and neuroprotective. Neurobiol Aging 21:475-496
6. Dubal DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW, Wise PM (1998) Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 18:1253-1258
7. Fuh J-L, Wang S-J, Lee S-J (2006) A longitudinal study of cognition change during early menopausal transition in a rural community. Maturitas 53:447-453
8. GanforninaMD, Do Carmo S, Martinez E, Tolivia J, Navarro A, Rassart E, Sanchez D (2010) Apo D, a glia-derived apolipoprotein, is required for peripheral nerve functional integrity and a timely response to injury. Glia 58:1320-1334
9. Gibson GE, Sheu KF, Blass JP (1998) Abnormalities of mitochondrial enzymes in Alzheimer disease. J Neural Transm 105:855-870
10. Henderson VW (2008) Cognitive changes after menopause: Influence of estrogen. Clin Obstet Gynecol 51(3):618-626
11. Henderson VW, Sherwin BB (2007) Surgical versus natural menopause: Cognitive issues. Menopause 14:572-579
12. Hosli E, Jurasin K, Ruhl W, Luthy R, Hosli L (2001) Colocalization of androgen, estrogen, and cholinergic receptors on cultured astrocytes of rat central nervous system. Int J Dev Neurosci 19:11-19
13. Janicki SC, Schupf N (2010) Hormonal influences on cognition and risk for Alzheimer's disease. Curr Neurol Neurosci Rep 10(5):359-366
14. Kang JH, Weuve J, Grodstein F (2004) Postmenopausal hormone therapy and risk of cognitive decline in communitydwelling aging women. Neurology 63:101-107
15. Kok HS, Kuh D, Cooper R et al (2006) Cognitive function across the life course and the menopausal transition in a British birth cohort. Menopause 13:19-27
16. Kuroki Y, Fukushima K, Kanda Y, Mizuno K, Watanabe Y (2000) Neuroprotection by estrogen via extracellular signalregulated kinase against quinolinic acid-induced cell death in the rat hippocampus. Eur J Neurosci 13:472-476
17. Lelu K, Laffont S, Delpy L, Polet PE, Perinat T, Tschanz SA, Pelletier L, Engelhardt B, Guéry JC (2011) Estrogen receptor a signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis. J Immunol 187:2386-2393
18. Mattson MP, Robinson N, Guo Q (1997) Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. Neuroreport 8:3817-3821
19. McCarthy MM (2009) The two faces of estradiol: Effects on the developing brain. Neuroscientist 15(6):599-610
20. Moosmann B, Behl C (1999) The antioxidant neuroprotective effect of estrogens and phenolic compounds are independent from their estrogenic properties. Proc Natl Acad Sci U S A 96:8867-8872
21. Nilsen J, Brinton RD (2004) Mitochondria as therapeutic targets of estrogen action in the central nervous system. Curr Drug Targets CNS Neurol Disord 3:297-313
22. Pérez C, Navarro A, Martínez E, Ordóñez C, Del Valle E, Tolivia J (2012) Age-related changes of apolipoprotein D expression in female rat central nervous system with chronic estradiol treatment. Age (Dordr). doi:10.1007/s11357-011-9286-5
23. RoccaWA, Grossardt BR, Shusterd LT (2010) Oophorectomy, menopause, estrogen, and cognitive aging: The timing hypothesis. Neurodegener Dis 7(1-3):163-166
24. SchumacherM, Akwa Y, Guennoun R, Robert F, Labombarda F, Desarnaud F, Robel P, De N, Baulieu EE (2000) Steroid synthesis and metabolism in the nervous system: Trophic and protective effects. J Neurocytol 29:307-326
25. Shaywitz SE, Shaywitz BA, Pugh KR (1999) Effect of estrogen on brain activation patterns in postmenopausalwomen during working memory tasks. JAMA 281:1197-1202
26. Shughrue PJ (2004) Estrogen attenuates the MPTP-induced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ER alpha and ER beta). Exp Neurol 190:468-477
27. Simpkins JW, Rajakumar G, Zhang YQ, Simpkins CE, Greenwald D, Yu CJ, Bodor N, Day AL (1997) Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J Neurosurg 87:724-730
28. Simpkins JW, Yi KD, Yang ShH, Dykens JA (2010) Mitochondrial mechanisms of estrogen neuroprotection. Biochim Biophys Acta 1800(10):1113-1120
29. Spampinato SF, Molinaro G, Merlo S, Iacovelli L, Caraci F (2012) Estrogen receptors and type-1 metabotropic glutamate receptors are interdependent in protecting cortical neurons against ß-amyloid toxicity. Mol Pharmacol 81(1):12-20
30. Wang L, Andersson S, Warner M, Gustafsson JA (2001) Morphological abnormalities in the brains of estrogen receptor beta knockout mice. Proc Natl Acad Sci U S A 98:2792-2796
31. Zheng J, Ramirez VD (1999) Purification and identification of an estrogen binding protein from rat brain: Oligomycin sensitivity-conferring protein (OSCP), a subunit of mitochondrial F0F1-ATP synthase/ATPase. J Steroid Biochem Mol Biol 68:65-75